These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 19552598

  • 1. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
    Ye P, Wu CE, Sheng L, Li H.
    J Altern Complement Med; 2009 Jul; 15(7):719-25. PubMed ID: 19552598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A, Haczyński J, Jołda-Mydłowska B, Witkowska M.
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T, Shigematsu M.
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Masaki M, Mano T, Eguchi A, Fujiwara S, Sugahara M, Hirotani S, Tsujino T, Komamura K, Koshiba M, Masuyama T.
    Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Müller-Brunotte R, Kahan T, López B, Edner M, González A, Díez J, Malmqvist K.
    J Hypertens; 2007 Sep; 25(9):1958-66. PubMed ID: 17762662
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
    Wachtell K, Palmieri V, Gerdts E, Bella JN, Aurigemma GP, Papademetriou V, Dahlöf B, Aalto T, Ibsen H, Rokkedal JE, Devereux RB.
    Am J Cardiol; 2010 Oct 01; 106(7):999-1005. PubMed ID: 20854964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M, D'Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G.
    J Hypertens; 2009 Oct 01; 27(10):2108-15. PubMed ID: 19564794
    [Abstract] [Full Text] [Related]

  • 19. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA, Shlyakhto EV, Konrady AO, Macsimova TA, Zaharov DV, Rudomanov OG.
    Med Sci Monit; 2000 Oct 01; 6(2):309-13. PubMed ID: 11208328
    [Abstract] [Full Text] [Related]

  • 20. Effect of amlodipine and lacidipine on left ventricular diastolic and long axis functions in arterial hypertension and stable angina pectoris.
    Zaliunas R, Jurkevicus R, Zabiela V, Brazdzionyte J.
    Acta Cardiol; 2005 Jun 01; 60(3):239-46. PubMed ID: 15999461
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.